Business
Ozempic maker Novo Nordisk plunges 22%. What could this mean for Resmed shares?
Image source: Getty Images
When a company sheds over $100 billion of market value in one day, you sit up and pay attention, especially when that company is one of the largest companies in Europe.
Novo Nordisk (NYSE: NVO), the Danish pharmaceutical giant that launched the semaglutide sold under…
Continue Reading